FDA Investigator Ivy E Sweeney
Ivy E Sweeney has conducted inspections on 31 sites in 4 countries as of 21 Aug 2017. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
31
Last Inspection Date:
21 Aug 2017
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
China,
Canada
FDA Investigators that have inspected at least one site in common with Ivy E Sweeney:
Alan P Kurtzberg,
Amanda M Osteen,
Andrew Saunders,
Anh M Lac,
Arsen Karapetyan,
Bijoy Panicker,
Bonita S Chester,
Bonnie E Conley,
Brandon C Heitmeier,
Brandy N Lepage,
Caitlin L Almonrode,
Carl A Huffman, III,
Carrie A Hughes,
Charvais S Hill,
Cherie T Parker,
Cheryl G Scott,
Christopher S Keating,
Claire M Minden,
Concepcion Cruz, Jr,
Dale A Nyberg,
Daniel J Roberts,
Decima L Thompson,
Decima L Washington,
Dell S Moller,
Demario L Walls,
Devaughn Edwards,
Edward Deberry,
Edward H Maticka,
Eileen A Liu,
Eric R Holm,
Felix Maldonado,
Gabriel R Mclemore,
George J Flynn,
George Pyramides,
Geraldine D Sanders,
Guerlain Ulysse,
James C Maclaughlin,
Jared P Stevens,
Jawaid Hamid,
Jennifer L Huntington,
John A Gonzalez,
Joshua P Wireman,
June P Page,
Katherine D Adams,
Kham Phommachanh,
Kimberly A Dutzek,
Kimberly L Mcmillan,
Lata C Mathew, PhD,
LCDR Debra Emerson,
Libia M Lugo,
Lillie D Witcher,
Linda A Gregory Duty,
Linda K Cline,
Margaret E Slimbach,
Marvin D Jones,
Matthew R Noonan,
Melanie M Walker,
Michael R Goga,
Muralidhara B Gavini, PhD,
Nadeem I Chaudhry,
Neda Hamandi,
Pankaj H Amin,
Patrick C Dooley,
Patsy J Domingo,
Penny H Mccarver,
Qin Xu,
Rajiv R Srivastava,
Reba A Gates,
Robert E Hultman,
Robert L Lewis, Jr,
Sandra A Boyd,
Sangeeta M Khurana, PhD,
Sarah E Mcmullen,
Sarah M Parkinson,
Sena G Dissmeyer,
Stephen G Mclane,
Steven D Dittert,
Susan O Oladeji,
Susanna E Ford,
Thomas B Smith,
Tracy J Washington,
Travis E Chapman,
Ucheabuchi Cchudi Nwankwor,
Vincent M Williams,
William A Warnick,
Yumi J Hiramine,
Yvins Dezan,
Zada L Giles
Ivy E Sweeney's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2017 | FDA 483 | MAGNESIUM DIRECT INC. - Form 483, 2017-02-03 |
July, 2015 | FDA 483 | PharMEDium Services, LLC. - Form 483, 2015-07-10 |
July, 2016 | FDA 483 | Jiangxi Sencen Hygienic Products Co., Ltd. - Form 483, 2016-07-21 |
April, 2016 | FDA 483 | Pisgah Laboratories Inc - Form 483, 2016-04-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more